Apogee Therapeutics, Inc. Common Stock (APGE) — Defensive Interval Ratio
Apogee Therapeutics, Inc. Common Stock (APGE) has a Defensive Interval Ratio of 8430 days as of June 2026. Defensive assets of $866.36 Million (cash $-, short-term investments $866.36 Million, receivables $-) cover 8430 days of daily cash needs of $102.77K/day.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Apogee Therapeutics, Inc. Common Stock Defensive Interval Ratio (2022–2025)
This chart shows how Apogee Therapeutics, Inc. Common Stock's Defensive Interval Ratio has evolved across 4 annual periods from 2022 to 2025. As of June 2026, the ratio stands at 8430 days, meaning defensive assets of $866.36 Million can fund 8430 days of operations without new revenue. For the complete balance sheet picture, see Apogee Therapeutics, Inc. Common Stock asset portfolio.
Annual Defensive Interval Ratio for Apogee Therapeutics, Inc. Common Stock (2022–2025)
The table below presents the year-by-year Defensive Interval Ratio for Apogee Therapeutics, Inc. Common Stock from 2022 to 2025, covering 4 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. See Apogee Therapeutics, Inc. Common Stock short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2025 | 7908 days | $604.60 Million | $76.45K/day | $- | $598.64 Million | ▲ +3006 days |
| 2024 | 4902 days | $383.56 Million | $78.25K/day | $- | $378.86 Million | ▼ -40 days |
| 2023 | 4942 days | $278.36 Million | $56.32K/day | $- | $277.14 Million | ▲ +4942 days |
| 2022 | 0 days | $0.00 | $27.34K/day | $- | $0.00 | — |